| Year |
Citation |
Score |
| 2023 |
Koofhethile CK, Gao C, Chang C, Lian X, Shapiro R, Yu XG, Lichterfeld M, Kanki P. The HIV-2 proviral landscape is dominated by defective proviruses. Aids (London, England). PMID 37916471 DOI: 10.1097/QAD.0000000000003776 |
0.542 |
|
| 2022 |
Chaplin B, Agbaji O, Nieva HR, Olatunde B, Chang C, Mitruka K, Sule H, Dajel T, Zee A, Ahmed ML, Ahmed I, Okonkwo P, Rawizza H, Kanki P. The Timeliness of Point of Care Viral Load Results Improves HIV Monitoring in Nigeria. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35872644 DOI: 10.1093/cid/ciac609 |
0.397 |
|
| 2022 |
Ogunbajo A, Mayer KH, Kanki PJ, Tsai AC. Intersectional Stigma and HIV Continuum Outcomes Among Sexual Minority Men in Sub-Saharan Africa: A Conceptual Framework. American Journal of Public Health. 112: S374-S376. PMID 35763733 DOI: 10.2105/AJPH.2021.306693 |
0.345 |
|
| 2022 |
Abah IO, Dayom WD, Dangiwa DA, Aderemi-Williams R, Anejo-Okopi J, Agbaji OO, Kanki P, Aguiyi JC. Comparative incidence of adverse drug reaction during the first and subsequent year of antiretroviral therapy in a Nigerian HIV infected Cohort. African Health Sciences. 21: 1027-1039. PMID 35222564 DOI: 10.4314/ahs.v21i3.10 |
0.369 |
|
| 2022 |
Ogunbajo A, Tsai AC, Kanki PJ, Mayer KH. Acceptability of and Preferences for Long-Acting Injectable HIV PrEP and Other PrEP Modalities among Sexual Minority Men in Nigeria, Africa. Aids and Behavior. PMID 35061117 DOI: 10.1007/s10461-022-03575-y |
0.475 |
|
| 2021 |
Bello FO, Akanmu AS, Adeyemo TA, Idowu BM, Okonkwo P, Kanki PJ. Derangement of protein S and C4b-binding protein levels as acquired thrombophilia in HIV-infected adult Nigerians. Southern African Journal of Hiv Medicine. 22: 1253. PMID 34522427 DOI: 10.4102/sajhivmed.v22i1.1253 |
0.443 |
|
| 2021 |
Farinre O, Gounder K, Reddy T, Tongo M, Hare J, Chaplin B, Gilmour J, Kanki P, Mann JK, Ndung'u T. Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa. Retrovirology. 18: 11. PMID 33952315 DOI: 10.1186/s12977-021-00554-4 |
0.386 |
|
| 2020 |
Miles BCH, Shpitser I, Kanki P, Meloni S, Tchetgen EJT. On semiparametric estimation of a path-specific effect in the presence of mediator-outcome confounding. Biometrika. 107: 159-172. PMID 33390591 DOI: 10.1093/Biomet/Asz063 |
0.671 |
|
| 2020 |
Rawizza HE, Oladokun R, Ejeliogu E, Oguche S, Ogunbosi BO, Agbaji O, Odaibo G, Imade G, Olaleye D, Wiesner L, Darin KM, Okonkwo P, Kanki PJ, Scarsi KK, McIlleron HM. Rifabutin pharmacokinetics and safety among TB/HIV-coinfected children receiving lopinavir/ritonavir-containing second-line ART. The Journal of Antimicrobial Chemotherapy. PMID 33294914 DOI: 10.1093/jac/dkaa512 |
0.365 |
|
| 2020 |
Okunade KS, Olowoselu OF, John-Olabode S, Hassan BO, Akinsola OJ, Nwogu CM, Ugwu AO, Moses OE, Rabiu KA, Ajepe A, Adenekan MA, Adejimi AA, Akanmu SA, Kanki PJ. Effects of selenium supplementation on pregnancy outcomes and disease progression in HIV-infected pregnant women in Lagos: A randomised controlled trial. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. PMID 33275775 DOI: 10.1002/ijgo.13514 |
0.355 |
|
| 2020 |
Koofhethile CK, Moyo S, Kotokwe KP, Chang CA, Mokgethi P, Muchoba L, Mokgweetsi S, Makhema J, Lockman S, Gaseitsiwe S, de Oliviera T, Essex M, Shapiro R, Kanki PJ, Novitsky V. Detection of inducible replication-competent HIV-1C provirus despite long-term antiretroviral treatment in perinatally infected adolescents in Botswana. Aids Research and Human Retroviruses. PMID 32935556 DOI: 10.1089/Aid.2020.0097 |
0.492 |
|
| 2020 |
Ogbenna AA, Meloni S, Inzaule S, Hamers RL, Sigaloff K, Osibogun A, Adeyemo TA, Okonkwo P, Samuels JO, Kanki PJ, Rinke de Wit TF, Akanmu AS. The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation. Plos One. 15: e0238027. PMID 32841264 DOI: 10.1371/Journal.Pone.0238027 |
0.753 |
|
| 2020 |
Meloni ST, Agaba P, Chang CA, Yiltok E, Oguche S, Ejeliogu E, Agbaji O, Okonkwo P, Kanki PJ. Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria. Plos One. 15: e0236801. PMID 32735566 DOI: 10.1371/Journal.Pone.0236801 |
0.735 |
|
| 2020 |
Nazziwa J, Faria NR, Chaplin B, Rawizza H, Kanki P, Dakum P, Abimiku A, Charurat M, Ndembi N, Esbjörnsson J. Characterisation of HIV-1 Molecular Epidemiology in Nigeria: Origin, Diversity, Demography and Geographic Spread. Scientific Reports. 10: 3468. PMID 32103028 DOI: 10.1038/S41598-020-59944-X |
0.599 |
|
| 2020 |
Onwuamah CK, Okpokwu J, Audu R, Imade G, Meloni ST, Okwuraiwe A, Chebu P, Musa AZ, Chaplin B, Dalhatu I, Agbaji O, Samuels J, Ezechi O, Ahmed M, Odaibo G, ... ... Kanki PJ, et al. Low levels of HIV-1 drug resistance mutations in patients who achieved viral re-suppression without regimen switch: a retrospective study. Bmc Microbiology. 20: 17. PMID 31959116 DOI: 10.1186/S12866-020-1706-1 |
0.757 |
|
| 2019 |
Koofhethile CK, Moyo S, Kotokwe KP, Mokgethi P, Muchoba L, Mokgweetsi S, Gaolathe T, Makhema J, Shapiro R, Lockman S, Kanki P, Essex M, Gaseitsiwe S, de Oliveira T, Novitsky V. Undetectable proviral deoxyribonucleic acid in an adolescent perinatally infected with human immunodeficiency virus-1C and on long-term antiretroviral therapy resulted in viral rebound following antiretroviral therapy termination: A case report with implications for clinical care. Medicine. 98: e18014. PMID 31764816 DOI: 10.1097/Md.0000000000018014 |
0.494 |
|
| 2019 |
Balogun M, Meloni ST, Igwilo UU, Roberts A, Okafor I, Sekoni A, Ogunsola F, Kanki PJ, Akanmu S. Status of HIV-infected patients classified as lost to follow up from a large antiretroviral program in southwest Nigeria. Plos One. 14: e0219903. PMID 31344057 DOI: 10.1371/Journal.Pone.0219903 |
0.761 |
|
| 2019 |
Balogun MR, Sekoni AO, Meloni ST, Odukoya OO, Onajole AT, Longe-Peters OA, Ogunsola FT, Kanki PJ. Predictors of tuberculosis knowledge, attitudes and practices in urban slums in Nigeria: a cross-sectional study. The Pan African Medical Journal. 32: 60. PMID 31223352 DOI: 10.11604/Pamj.2019.32.60.14622 |
0.621 |
|
| 2019 |
Rawizza HE, Darin KM, Oladokun R, Brown B, Ogunbosi B, David N, Akanmu S, Olaitan O, Chang C, Scarsi KK, Okonkwo P, Kanki PJ. Safety and efficacy of rifabutin among HIV/TB-coinfected children on lopinavir/ritonavir-based ART. The Journal of Antimicrobial Chemotherapy. PMID 31139825 DOI: 10.1093/jac/dkz219 |
0.339 |
|
| 2019 |
Meloni ST, Agbaji O, Chang CA, Agaba P, Imade G, Oguche S, Mukhtar A, Mitruka K, Cox MH, Zee A, Kanki P. The role of point-of-care viral load monitoring in achieving the target of 90% suppression in HIV-infected patients in Nigeria: study protocol for a randomized controlled trial. Bmc Infectious Diseases. 19: 368. PMID 31046695 DOI: 10.1186/S12879-019-3983-6 |
0.718 |
|
| 2019 |
Abah IO, Ncube NB, Bradley HA, AgbaJi OO, Kanki P. Antiretroviral Therapy-associated Adverse Drug Reactions and their Effects on Virologic Failure- A Retrospective Cohort Study in Nigeria. Current Hiv Research. PMID 30767743 DOI: 10.2174/1389450120666190214144609 |
0.333 |
|
| 2019 |
Agbaji OO, Abah IO, Ebonyi AO, Gimba ZM, Abene EE, Gomerep SS, Falang KD, Anejo-Okopi J, Agaba PA, Ugoagwu PO, Agaba EI, Imade GE, Sagay AS, Okonkwo P, Idoko JA, ... Kanki PJ, et al. Long Term Exposure to Tenofovir Disoproxil Fumarate-Containing Antiretroviral Therapy Is Associated with Renal Impairment in an African Cohort of HIV-Infected Adults. Journal of the International Association of Providers of Aids Care. 18: 2325958218821963. PMID 30672363 DOI: 10.1177/2325958218821963 |
0.34 |
|
| 2018 |
Chaplin B, Akanmu AS, Inzaule SC, Samuels JO, Okonkwo P, Ilesanmi O, Adewole IFA, Asadu C, Khamofu H, Mpazanje R, Ndembi N, Odafe S, Sigaloff KCE, Ngige EN, Abatta EO, ... ... Kanki P, et al. Association between HIV-1 subtype and drug resistance in Nigerian infants. The Journal of Antimicrobial Chemotherapy. PMID 30260417 DOI: 10.1093/Jac/Dky380 |
0.537 |
|
| 2018 |
Agaba PA, Genberg BL, Sagay AS, Agbaji OO, Meloni ST, Dadem NY, Kolawole GO, Okonkwo P, Kanki PJ, Ware NC. Retention in Differentiated Care: Multiple Measures Analysis for a Decentralized HIV Care and Treatment Program in North Central Nigeria. Journal of Aids & Clinical Research. 9. PMID 29682399 DOI: 10.4172/2155-6113.1000756 |
0.763 |
|
| 2017 |
Miles CH, Shpitser I, Kanki P, Meloni S, Tchetgen EJT. Quantifying an Adherence Path-Specific Effect of Antiretroviral Therapy in the Nigeria PEPFAR Program. Journal of the American Statistical Association. 112: 1443-1452. PMID 32042214 DOI: 10.1080/01621459.2017.1295862 |
0.734 |
|
| 2017 |
Agaba PA, Meloni ST, Sule HM, Agbaji OO, Sagay AS, Okonkwo P, Idoko JA, Kanki PJ. Treatment Outcomes Among Older Human Immunodeficiency Virus-Infected Adults in Nigeria. Open Forum Infectious Diseases. 4: ofx031. PMID 29497627 DOI: 10.1093/Ofid/Ofx031 |
0.657 |
|
| 2017 |
Meloni ST, Onwuamah CK, Agbaji O, Chaplin B, Olaleye DO, Audu R, Samuels J, Ezechi O, Imade G, Musa AZ, Odaibo G, Okpokwu J, Rawizza H, Mu'azu MA, Dalhatu I, ... ... Kanki PJ, et al. Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options. Open Forum Infectious Diseases. 4: ofx233. PMID 29255731 DOI: 10.1093/Ofid/Ofx233 |
0.669 |
|
| 2017 |
Chaplin B, Imade GE, Onwuamah C, Odaibo G, Audu R, Okpokwu J, Olaleye DO, Meloni S, Rawizza H, Muazu M, Musa AZ, Samuels J, Agbaji O, Ezechi O, Idigbe E, ... Kanki PJ, et al. Distinct pattern of TAMs with K65R in patients failing tenofovir-based antiretroviral therapy. Aids Research and Human Retroviruses. PMID 29084434 DOI: 10.1089/Aid.2017.0198 |
0.725 |
|
| 2017 |
Meloni ST, Chaplin B, Idoko J, Agbaji O, Akanmu S, Imade G, Okonkwo P, Murphy RL, Kanki PJ. Drug resistance patterns following pharmacy stock shortage in Nigerian Antiretroviral Treatment Program. Aids Research and Therapy. 14: 58. PMID 29029637 DOI: 10.1186/S12981-017-0184-5 |
0.673 |
|
| 2017 |
Agaba P, Meloni S, Sule H, Ocheke A, Agaba E, Idoko J, Kanki P. Factors associated with early menopause among women in Nigeria. Journal of Virus Eradication. 3: 145-151. PMID 28758022 DOI: 10.1016/S2055-6640(20)30333-2 |
0.804 |
|
| 2017 |
Agaba PA, Meloni ST, Sule HM, Ocheke AN, Agaba EI, Idoko JA, Kanki PJ. Prevalence and predictors of severe menopause symptoms among HIV-positive and -negative Nigerian women. International Journal of Std & Aids. 956462417704778. PMID 28409538 DOI: 10.1177/0956462417704778 |
0.735 |
|
| 2017 |
Rhee SY, Varghese V, Holmes SP, Van Zyl GU, Steegen K, Boyd MA, Cooper DA, Nsanzimana S, Saravanan S, Charpentier C, de Oliveira T, Etiebet MA, Garcia F, Goedhals D, Gomes P, ... ... Kanki P, et al. Mutational correlates of virological failure in individuals receiving a WHO-recommended tenofovir-containing first-line regimen: An international collaboration. Ebiomedicine. PMID 28365230 DOI: 10.1016/J.Ebiom.2017.03.024 |
0.305 |
|
| 2017 |
Agaba PA, Meloni ST, Sule HM, Agaba EI, Idoko JA, Kanki PJ. Sexual dysfunction and its determinants among women infected with HIV. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. PMID 28273350 DOI: 10.1002/Ijgo.12140 |
0.733 |
|
| 2017 |
Miles C, Kanki P, Meloni S, Tchetgen Tchetgen E. On Partial Identification of the Natural Indirect Effect Journal of Causal Inference. 5. DOI: 10.1515/jci-2016-0004 |
0.626 |
|
| 2017 |
Bassi P, Gashau W, Olaf K, Dodoo A, Okonkwo P, Kanki P. PREVALENCE OF ADVERSE DRUG REACTIONS AMONG HIV/AIDS PATIENTS ON HAART IN UNIVERSITY OF MAIDUGURI TEACHING HOSPITAL (UMTH), NIGERIA: A FOUR-YEAR RETROSPECTIVE STUDY Bmj Global Health. 2: A39.2-A39. DOI: 10.1136/Bmjgh-2016-000260.103 |
0.519 |
|
| 2016 |
Ebonyi AO, Oguche S, Agbaji OO, Sagay AS, Okonkwo PI, Idoko JA, Kanki PJ. Mortality among pulmonary tuberculosis and HIV-1 co-infected Nigerian children being treated for pulmonary tuberculosis and on antiretroviral therapy: a retrospective cohort study. Germs. 6: 139-150. PMID 28053917 DOI: 10.11599/germs.2016.1099 |
0.379 |
|
| 2016 |
Gregson J, Kaleebu P, Marconi VC, van Vuuren C, Ndembi N, Hamers RL, Kanki P, Hoffmann CJ, Lockman S, Pillay D, de Oliveira T, Clumeck N, Hunt G, Kerschberger B, Shafer RW, et al. Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study. The Lancet. Infectious Diseases. PMID 27914856 DOI: 10.1016/S1473-3099(16)30469-8 |
0.495 |
|
| 2016 |
Meloni ST, Chang CA, Eisen G, Jolayemi T, Banigbe B, Okonkwo PI, Kanki PJ. Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria. Plos One. 11: e0164030. PMID 27764094 DOI: 10.1371/Journal.Pone.0164030 |
0.649 |
|
| 2016 |
Ebonyi AO, Oguche S, Ejeliogu EU, Agbaji OO, Shehu NY, Abah IO, Sagay AS, Ugoagwu PO, Okonkwo PI, Idoko JA, Kanki PJ. Prevalence of and risk factors for pulmonary tuberculosis among newly diagnosed HIV-1 infected Nigerian children. Germs. 6: 21-8. PMID 27019829 DOI: 10.11599/germs.2016.1085 |
0.453 |
|
| 2016 |
Scarsi KK, Eisen G, Darin KM, Meloni ST, Rawizza HE, Tchetgen Tchetgen EJ, Agbaji OO, Onwujekwe DI, Gashau W, Nkado R, Okonkwo P, Murphy RL, Kanki PJ. Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: 512-8. PMID 26561532 DOI: 10.1093/Cid/Civ928 |
0.661 |
|
| 2016 |
Gregson J, Tang M, Ndembi N, Hamers RL, Marconi VC, Brooks K, Theys K, Arruda M, Garcia F, Monge S, Kanki PJ, Kumarasamy N, Kerschberger B, Mor O, Charpentier C, et al. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: A multicentre retrospective cohort study The Lancet Infectious Diseases. 16: 565-575. DOI: 10.1016/S1473-3099(15)00536-8 |
0.404 |
|
| 2015 |
Audu RA, Okoye RN, Onwuamah CK, Ige FA, Musa AZ, Odunukwe NN, Onwujekwe DI, Ezechi OC, Idigbe EO, Kanki PJ. Potential for false-positive HIV test results using rapid HIV testing algorithms. African Journal of Laboratory Medicine. 4: 178. PMID 38440311 DOI: 10.4102/ajlm.v4i1.178 |
0.481 |
|
| 2015 |
Hamel DJ, Sankalé JL, Samuels JO, Sarr AD, Chaplin B, Ofuche E, Meloni ST, Okonkwo P, Kanki PJ. Building laboratory capacity to support HIV care in Nigeria: Harvard/APIN PEPFAR, 2004-2012. African Journal of Laboratory Medicine. 4. PMID 26900573 DOI: 10.4102/Ajlm.V4I1.190 |
0.749 |
|
| 2015 |
Chang CA, Meloni ST, Eisen G, Chaplin B, Akande P, Okonkwo P, Rawizza HE, Tchetgen Tchetgen E, Kanki PJ. Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria. Open Forum Infectious Diseases. 2: ofv154. PMID 26613097 DOI: 10.1093/Ofid/Ofv154 |
0.741 |
|
| 2015 |
Abah IO, Akanbi M, Abah ME, Finangwai AI, Dady CW, Falang KD, Ebonyi AO, Okopi JA, Agbaji OO, Sagay AS, Okonkwo P, Idoko JA, Kanki PJ. Incidence and predictors of adverse drug events in an African cohort of HIV-infected adults treated with efavirenz. Germs. 5: 83-91. PMID 26405676 DOI: 10.11599/germs.2015.1075 |
0.409 |
|
| 2015 |
Meloni ST, Chaplin B, Chang C, Rawizza H, Okonkwo P, Kanki PJ. Patterns of Adherence and Loss to Follow-Up in Pediatric Patients on ART in Nigeria. Current Hiv Research. 13: 210-8. PMID 25986372 DOI: 10.2174/1570162X1303150506183921 |
0.721 |
|
| 2015 |
Rawizza HE, Chang CA, Chaplin B, Ahmed IA, Meloni ST, Oyebode T, Banigbe B, Sagay AS, Adewole IF, Okonkwo P, Kanki PJ, The Apin Pepfar Team EY. Loss to Follow-Up within the Prevention of Mother-to-Child Transmission Care Cascade in a Large ART Program in Nigeria. Current Hiv Research. 13: 201-209. PMID 25986371 DOI: 10.2174/1570162X1303150506183256 |
0.725 |
|
| 2015 |
Sagay AS, Ebonyi AO, Meloni ST, Musa J, Oguche S, Ekwempu CC, Oyebode T, Ejeliogu E, Imade GE, Agbaji OO, Okonkwo P, Kanki PJ. Mother-to-Child Transmission Outcomes of HIV-Exposed Infants Followed Up in Jos North-Central Nigeria. Current Hiv Research. 13: 193-200. PMID 25986370 DOI: 10.2174/1570162X1303150506182534 |
0.747 |
|
| 2015 |
Agbaji OO, Abah IO, Falang KD, Ebonyi AO, Musa J, Ugoagwu P, Agaba PA, Sagay AS, Jolayemi T, Okonkwo P, Idoko JA, Kanki PJ. Treatment Discontinuation in Adult HIV-Infected Patients on First-Line Antiretroviral Therapy in Nigeria. Current Hiv Research. 13: 184-92. PMID 25986369 |
0.499 |
|
| 2015 |
Kanki PJ. Editorial: Programmatic Evaluation of HIV Prevention and Treatment in Nigeria. Current Hiv Research. 13: 174-5. PMID 25986367 DOI: 10.2174/1570162x1303150506180843 |
0.48 |
|
| 2015 |
Abah IO, Darin KM, Ebonyi AO, Ugoagwu P, Ojeh VB, Nasir N, Falang KD, Olaitan O, Agbaji O, Idoko J, Kanki P. Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria. Journal of the International Association of Providers of Aids Care. 14: 348-54. PMID 25566781 DOI: 10.1177/2325957414565508 |
0.549 |
|
| 2015 |
Balogun M, Sekoni A, Meloni ST, Odukoya O, Onajole A, Longe-Peters O, Ogunsola F, Kanki PJ. Trained community volunteers improve tuberculosis knowledge and attitudes among adults in a periurban community in southwest Nigeria. The American Journal of Tropical Medicine and Hygiene. 92: 625-32. PMID 25510722 DOI: 10.4269/Ajtmh.14-0527 |
0.619 |
|
| 2015 |
Kuti MA, Adesina OA, Awolude OA, Ogunbosi BO, Fayemiwo SA, Akinyemi JO, Adetunji AA, Irabor AE, Odaibo GN, Prosper O, Taiwo BO, Olaleye D, Murphy RL, Kanki P, Adewole IF. Dyslipidemia in ART-Naive HIV-Infected Persons in Nigeria--Implications for Care. Journal of the International Association of Providers of Aids Care. 14: 355-9. PMID 25331224 DOI: 10.1177/2325957414555227 |
0.563 |
|
| 2015 |
Chaplin B, Meloni S, Eisen G, Jolayemi T, Banigbe B, Adeola J, Wen C, Reyes Nieva H, Chang C, Okonkwo P, Kanki P. Scale-up of networked HIV treatment in Nigeria: creation of an integrated electronic medical records system. International Journal of Medical Informatics. 84: 58-68. PMID 25301692 DOI: 10.1016/J.Ijmedinf.2014.09.006 |
0.74 |
|
| 2015 |
Kanki PJ. Programmatic evaluation of hiv prevention and treatment in Nigeria Current Hiv Research. 13: 174-175. |
0.48 |
|
| 2014 |
Ebonyi AO, Oguche S, Meloni ST, Sagay SA, Kyriacou DN, Achenbach CJ, Agbaji OO, Oyebode TA, Okonkwo P, Idoko JA, Kanki PJ. Predictors of Mortality in a Clinic Cohort of HIV-1 Infected Children Initiated on Antiretroviral Therapy in Jos, Nigeria. Journal of Aids & Clinical Research. 5. PMID 30416842 DOI: 10.4172/2155-6113.1000403 |
0.765 |
|
| 2014 |
Imade GE, Musa J, Sagay AS, Kapiga SH, Sankale JL, Idoko J, Kanki P. Association of Bacterial vaginosis and other Sexually Transmitted Infections with HIV among pregnant women in Nigeria. African Journal of Medicine and Medical Sciences. 43: 23-28. PMID 26681823 |
0.375 |
|
| 2014 |
Meloni ST, Chang C, Chaplin B, Rawizza H, Jolayemi O, Banigbe B, Okonkwo P, Kanki P. Time-Dependent Predictors of Loss to Follow-Up in a Large HIV Treatment Cohort in Nigeria. Open Forum Infectious Diseases. 1: ofu055. PMID 25734125 DOI: 10.1093/Ofid/Ofu055 |
0.74 |
|
| 2014 |
Olaleye DO, Odaibo GN, Carney P, Agbaji O, Sagay AS, Muktar H, Akinyinka OO, Omigbodun AO, Ogunniyi A, Gashau W, Akanmu S, Ogunsola F, Chukwuka C, Okonkwo PI, Meloni ST, ... ... Kanki PJ, et al. Enhancement of health research capacity in Nigeria through north-south and in-country partnerships. Academic Medicine : Journal of the Association of American Medical Colleges. 89: S93-7. PMID 25072590 DOI: 10.1097/Acm.0000000000000353 |
0.612 |
|
| 2014 |
Kanki PJ, Rowland-Jones S. The protective effect of HIV-2 infection: implications for understanding HIV-1 immunity. Aids (London, England). 28: 1065-7. PMID 24685743 DOI: 10.1097/QAD.0000000000000209 |
0.518 |
|
| 2014 |
Agaba PA, Meloni ST, Sule HM, Agbaji OO, Ekeh PN, Job GC, Nyango N, Ugoagwu PO, Imade GE, Idoko JA, Kanki PJ. Patients who present late to HIV care and associated risk factors in Nigeria. Hiv Medicine. 15: 396-405. PMID 24580742 DOI: 10.1111/Hiv.12125 |
0.767 |
|
| 2014 |
Imade GE, Sagay AS, Chaplin B, Chebu P, Musa J, Okpokwu J, Hamel DJ, Pam IC, Agbaji O, Samuels J, Meloni S, Sankale JL, Okonkwo P, Kanki P. Short communication: Transmitted HIV drug resistance in antiretroviral-naive pregnant women in north central Nigeria. Aids Research and Human Retroviruses. 30: 127-33. PMID 24164431 DOI: 10.1089/Aid.2013.0074 |
0.798 |
|
| 2013 |
Ladep NG, Agbaji OO, Agaba PA, Muazu A, Ugoagwu P, Imade G, Cooke GS, Vivas L, Cormack SM, Taylor-Robinson SD, Idoko J, Kanki P. Hepatitis B Co-Infection is Associated with Poorer Survival of HIV-Infected Patients on Highly Active Antiretroviral Therapy in West Africa. Journal of Aids & Clinical Research. PMID 25328814 DOI: 10.4172/2155-6113.S3-006 |
0.577 |
|
| 2013 |
Imade GE, Sagay AS, Musa J, Ocheke AN, Adeniyi DS, Idighri M, Powl R, Sendeht A, Ogwuche JP, Elujoba M, Egbodo CO, Oyebode T, Daru PH, Agbaji O, Pam IC, ... ... Kanki PJ, et al. Declining rate of infection with maternal human immunodeficiency virus at delivery units in north-central Nigeria. African Journal of Reproductive Health. 17: 138-45. PMID 24689325 |
0.79 |
|
| 2013 |
Rawizza HE, Chaplin B, Meloni ST, Darin KM, Olaitan O, Scarsi KK, Onwuamah CK, Audu RA, Chebu PR, Imade GE, Okonkwo P, Kanki PJ. Accumulation of protease mutations among patients failing second-line antiretroviral therapy and response to salvage therapy in Nigeria. Plos One. 8: e73582. PMID 24069209 DOI: 10.1371/Journal.Pone.0073582 |
0.659 |
|
| 2013 |
Falade CO, Adesina-Adewole B, Dada-Adegbola HO, Ajayi IO, Akinyemi JO, Ademowo OG, Adewole IF, Kanki P. Evaluation of Paracheck-Pf™ rapid malaria diagnostic test for the diagnosis of malaria among HIV-positive patients in Ibadan, South-Western Nigeria Pathogens and Global Health. 107: 69-77. PMID 23683333 DOI: 10.1179/2047773213Y.0000000077 |
0.38 |
|
| 2013 |
Ladep NG, Agaba PA, Agbaji O, Muazu A, Ugoagwu P, Imade G, Cooke G, McCormack S, Taylor-Robinson SD, Idoko J, Kanki P. Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort. World Journal of Gastroenterology : Wjg. 19: 1602-10. PMID 23538773 DOI: 10.3748/Wjg.V19.I10.1602 |
0.499 |
|
| 2013 |
Dinic L, Idigbe OE, Meloni S, Rawizza H, Akande P, Eisen G, Onwujekwe D, Agbaji O, Ani A, Kanki PJ. Sputum smear concentration may misidentify acid-fast bacilli as Mycobacterium tuberculosis in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes (1999). 63: 168-77. PMID 23392466 DOI: 10.1097/Qai.0B013E31828983B9 |
0.817 |
|
| 2013 |
Akanbi MO, Achenbach CJ, Feinglass J, Taiwo B, Onu A, Pho MT, Agbaji O, Kanki P, Murphy RL. Tuberculosis after one year of combination antiretroviral therapy in Nigeria: a retrospective cohort study. Aids Research and Human Retroviruses. 29: 931-7. PMID 23316724 DOI: 10.1089/Aid.2012.0231 |
0.49 |
|
| 2013 |
Agbaji O, Thio CL, Meloni S, Graham C, Muazu M, Nimzing L, Idoko J, Sankalé JL, Ekong E, Murphy R, Kanki P, Hawkins C. Impact of hepatitis C virus on HIV response to antiretroviral therapy in Nigeria. Journal of Acquired Immune Deficiency Syndromes (1999). 62: 204-7. PMID 23196830 DOI: 10.1097/Qai.0B013E31827Ce536 |
0.767 |
|
| 2013 |
Agbaji O, Ebonyi AO, Meloni ST, Anejo-Okopi JA, Akanbi MO, Oguche S, Agaba PA, Sagay AS, Okonkwo P, Kanki P. Factors associated with pulmonary tuberculosis-HIV co-infection in Treatment-Naive Adults in Jos, North Central Nigeria Journal of Aids and Clinical Research. 4. DOI: 10.4172/2155-6113.1000222 |
0.804 |
|
| 2013 |
Ulenga N, Kanki PJ. HIV treatment scale-up in Africa: The impact of drug resistance Hiv/Aids Treatment in Resource Poor Countries: Public Health Challenges. 45-56. DOI: 10.1007/978-1-4614-4520-3_5 |
0.779 |
|
| 2012 |
Kanki P, Kakkattil P, Simao M. Scaling up HIV treatment and prevention through national responses and innovative leadership. Journal of Acquired Immune Deficiency Syndromes (1999). 60: S27-30. PMID 22772386 DOI: 10.1097/Qai.0B013E31825C16Bb |
0.504 |
|
| 2012 |
Dinic L, Akande P, Idigbe EO, Ani A, Onwujekwe D, Agbaji O, Akanbi M, Nwosu R, Adeniyi B, Wahab M, Lekuk C, Kunle-Ope C, Nwokoye N, Kanki P. Genetic determinants of drug-resistant tuberculosis among HIV-infected patients in Nigeria. Journal of Clinical Microbiology. 50: 2905-9. PMID 22740709 DOI: 10.1128/Jcm.00982-12 |
0.828 |
|
| 2012 |
Kanki P, Ulenga N, Chaplin B. AF4 HIV Drug Resistance in Nigeria, a Cost-Effective New Methodology Jaids Journal of Acquired Immune Deficiency Syndromes. 59: 28. DOI: 10.1097/01.Qai.0000413824.50049.A5 |
0.753 |
|
| 2011 |
Agbaji OO, Agaba PA, Idoko JA, Taiwo B, Murphy R, Kanki P, Ekong E. Temporal changes in renal glomerular function associated with the use of Tenofovir Disoproxil Fumarate in HIV-infected Nigerians West African Journal of Medicine. 30: 164-168. PMID 22120479 |
0.381 |
|
| 2011 |
Rawizza HE, Chaplin B, Meloni ST, Eisen G, Rao T, Sankalé JL, Dieng-Sarr A, Agbaji O, Onwujekwe DI, Gashau W, Nkado R, Ekong E, Okonkwo P, Murphy RL, Kanki PJ, et al. Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 53: 1283-90. PMID 22080121 DOI: 10.1093/Cid/Cir729 |
0.694 |
|
| 2011 |
Agaba PA, Digin E, Makai R, Apena L, Agbaji OO, Idoko JA, Murphy R, Kanki P. Clinical characteristics and predictors of mortality in hospitalized HIV-infected Nigerians. Journal of Infection in Developing Countries. 5: 377-82. PMID 21628815 DOI: 10.3855/Jidc.1096 |
0.553 |
|
| 2011 |
Brown BJ, Oladokun RE, Osinusi K, Ochigbo S, Adewole IF, Kanki P. Disclosure of HIV status to infected children in a Nigerian HIV Care Programme. Aids Care. 23: 1053-8. PMID 21476150 DOI: 10.1080/09540121.2011.554523 |
0.452 |
|
| 2011 |
Brown BJ, Oladokun RE, Odaibo GN, Olaleye DO, Osinusi K, Kanki P. Clinical and Immunological Profile of Pediatric HIV Infection in Ibadan, Nigeria. Journal of the International Association of Physicians in Aids Care (Chicago, Ill. : 2002). 10: 49-53. PMID 21368015 DOI: 10.1177/1545109710385124 |
0.516 |
|
| 2011 |
Chaplin B, Eisen G, Idoko J, Onwujekwe D, Idigbe E, Adewole I, Gashau W, Meloni S, Sarr AD, Sankalé JL, Ekong E, Murphy RL, Kanki P. Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy Aids Research and Human Retroviruses. 27: 71-80. PMID 20964479 DOI: 10.1089/Aid.2010.0050 |
0.74 |
|
| 2010 |
Oladokun RE, Awolude O, Brown BJ, Adesina O, Oladokun A, Roberts A, Odaibo G, Osinusi K, Olaleye D, Adewole IF, Kanki P. Service uptake and performance of the prevention of mother-to-child transmission (PMTCT) programme in Ibadan, Nigeria African Journal of Medicine and Medical Sciences. 39: 81-87. PMID 21117403 |
0.33 |
|
| 2010 |
Akinyemi JO, Awolude OA, Adewole IF, Kanki PJ. Condom use among antiretroviral therapy patients in Ibadan, Nigeria. Journal of Infection in Developing Countries. 4: 495-502. PMID 20818101 |
0.456 |
|
| 2010 |
Taiwo B, Chaplin B, Penugonda S, Meloni S, Akanmu S, Gashau W, Idoko J, Adewole I, Murphy R, Kanki P. Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1. Current Hiv Research. 8: 194-8. PMID 20163340 DOI: 10.2174/157016210791111098 |
0.757 |
|
| 2009 |
Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C, Sankalé JL, Ekong E, Murphy R, Kanki P, Thio CL. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 1268-73. PMID 19772386 DOI: 10.1086/605675 |
0.802 |
|
| 2009 |
Hawkins CA, Chaplin B, Idoko J, Ekong E, Adewole I, Gashau W, Murphy RL, Kanki P. Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first-line antiretroviral therapy in Nigeria. Journal of Acquired Immune Deficiency Syndromes (1999). 52: 228-34. PMID 19644383 DOI: 10.1097/Qai.0B013E3181B06125 |
0.566 |
|
| 2009 |
Strong CL, Lanchy JM, Dieng-Sarr A, Kanki PJ, Lodmell JS. A 5'UTR-spliced mRNA isoform is specialized for enhanced HIV-2 gag translation. Journal of Molecular Biology. 391: 426-37. PMID 19559029 DOI: 10.1016/J.Jmb.2009.06.046 |
0.323 |
|
| 2009 |
Agaba PA, Sule HM, Ojoh RO, Hassan Z, Apena L, Mu'Azu MA, Badung B, Agbaji OO, Idoko JA, Kanki P. Presentation and survival of patients with AIDS-related Kaposi's sarcoma in Jos, Nigeria International Journal of Std and Aids. 20: 410-413. PMID 19451327 DOI: 10.1258/Ijsa.2008.008353 |
0.511 |
|
| 2008 |
Ulenga NK, Sarr AD, Hamel D, Sankale JL, Mboup S, Kanki PJ. The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals. Aids Research and Human Retroviruses. 24: 1285-90. PMID 18851679 DOI: 10.1089/Aid.2008.0072 |
0.756 |
|
| 2008 |
Ojesina AI, Chaplin B, Sankalé JL, Murphy R, Idigbe E, Adewole I, Ekong E, Idoko J, Kanki PJ. Interplay of reverse transcriptase inhibitor therapy and gag p6 diversity in HIV type 1 subtype G and CRF02_AG. Aids Research and Human Retroviruses. 24: 1167-74. PMID 18729771 DOI: 10.1089/Aid.2007.0308 |
0.71 |
|
| 2008 |
Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, Adewole IF, Olaleye DO, Murphy R, Kanki P. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Annals of Hepatology. 7: 152-6. PMID 18626434 DOI: 10.1016/S1665-2681(19)31872-1 |
0.525 |
|
| 2008 |
Ulenga NK, Sarr AD, Thakore-Meloni S, Sankalé JL, Eisen G, Kanki PJ. Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F. The Journal of Infectious Diseases. 198: 486-92. PMID 18598197 DOI: 10.1086/590212 |
0.723 |
|
| 2008 |
Agaba P, Thacher T, Ekwempu C, Adisa J, Agbaji O, Idoko J, Kanki P. Reproductive-Organ Disease in HIV-Positive Nigerian Women: Does Highly Active Antiretroviral Therapy (HAART) Make a Difference? International Journal of Infectious Diseases. 12: e202. DOI: 10.1016/J.Ijid.2008.05.501 |
0.501 |
|
| 2007 |
Ojesina AI, Mullins C, Imade G, Samuels J, Sankalé JL, Pam S, Sagay S, Idoko J, Kanki PJ. Characterization of HIV type 1 reverse transcriptase mutations in infants infected by mothers who received peripartum nevirapine prophylaxis in Jos, Nigeria. Aids Research and Human Retroviruses. 23: 1587-92. PMID 18160018 DOI: 10.1089/Aid.2007.0064 |
0.72 |
|
| 2007 |
Idoko JA, Agbaji O, Agaba P, Akolo C, Inuwa B, Hassan Z, Akintunde L, Badung B, Muazu M, Danang M, Imade G, Sankale JL, Kanki P. Direct observation therapy-highly active antiretroviral therapy in a resource-limited setting: the use of community treatment support can be effective. International Journal of Std & Aids. 18: 760-3. PMID 18005510 DOI: 10.1258/095646207782212252 |
0.353 |
|
| 2007 |
Hamel DJ, Sankalé JL, Eisen G, Meloni ST, Mullins C, Gueye-Ndiaye A, Mboup S, Kanki PJ. Twenty years of prospective molecular epidemiology in Senegal: changes in HIV diversity. Aids Research and Human Retroviruses. 23: 1189-96. PMID 17961103 DOI: 10.1089/Aid.2007.0037 |
0.797 |
|
| 2007 |
Ladep NG, Agbaji O, Agaba P, Badung P, Imade G, Sankalé J, Idoko J, Kanki P. Does immunological status affect the prevalence of Hepatitis C virus infection among HIV/AIDS patients? Nigerian Journal of Medicine : Journal of the National Association of Resident Doctors of Nigeria. 16: 231-234. PMID 17937159 |
0.444 |
|
| 2007 |
Sankalé JL, Langevin S, Odaibo G, Meloni ST, Ojesina AI, Olaleye D, Kanki P. The complexity of circulating HIV type 1 strains in Oyo state, Nigeria. Aids Research and Human Retroviruses. 23: 1020-5. PMID 17725419 DOI: 10.1089/Aid.2006.0304 |
0.814 |
|
| 2007 |
MacNeil A, Sarr AD, Sankalé JL, Meloni ST, Mboup S, Kanki P. Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection. Journal of Virology. 81: 5325-30. PMID 17329334 DOI: 10.1128/Jvi.02625-06 |
0.811 |
|
| 2007 |
Rodriguez SK, Sarr AD, MacNeil A, Thakore-Meloni S, Gueye-Ndiaye A, Traoré I, Dia MC, Mboup S, Kanki PJ. Comparison of heterologous neutralizing antibody responses of human immunodeficiency virus type 1 (HIV-1)- and HIV-2-infected Senegalese patients: distinct patterns of breadth and magnitude distinguish HIV-1 and HIV-2 infections. Journal of Virology. 81: 5331-8. PMID 17301136 DOI: 10.1128/Jvi.02789-06 |
0.85 |
|
| 2007 |
MacNeil A, Sankale JL, Meloni ST, Sarr AD, Mboup S, Kanki P. Long-term intrapatient viral evolution during HIV-2 infection. The Journal of Infectious Diseases. 195: 726-33. PMID 17262716 DOI: 10.1086/511308 |
0.813 |
|
| 2007 |
Lar P, Lar N, Bemis K, Jelpe J, Enzyguirre L, Ayuba L, Zella D, Kanki P, Carr JK, Blattner W, Abimiku AG. HIV subtype and drug resistance patterns among drug naïve persons in Jos, Nigeria African Journal of Biotechnology. 6: 1892-1897. |
0.358 |
|
| 2006 |
Sagay AS, Musa J, Ekwempu CC, Imade GE, Babalola A, Daniyan G, Malu N, Idoko JA, Kanki P. Partner disclosure of HIV status among HIV positive mothers in Northern Nigeria African Journal of Medicine and Medical Sciences. 35: 119-123. PMID 18050785 |
0.501 |
|
| 2006 |
Ojesina AI, Kanki PJ. HIV-1 subtype and reverse transcriptase genotype: role for geographical location and founder effects. Plos Medicine. 3: e540. PMID 17194205 DOI: 10.1371/Journal.Pmed.0030540 |
0.718 |
|
| 2006 |
Sagay AS, Musa J, Adewole AS, Imade GE, Ekwempu CC, Kapiga S, Sankale JL, Idoko J, Kanki P. Rapid HIV testing and counselling in labour in a northern Nigerian setting African Journal of Reproductive Health.. 10: 76-80. PMID 16999197 DOI: 10.2307/30032446 |
0.567 |
|
| 2006 |
Rodriguez SK, Sarr AD, Olorunnipa O, Popper SJ, Gueye-Ndiaye A, Traoré I, Dia MC, Mboup S, Kanki PJ. The absence of anti-Tat antibodies is associated with risk of disease progression in HIV-2 infection. The Journal of Infectious Diseases. 194: 760-3. PMID 16941341 DOI: 10.1086/507042 |
0.836 |
|
| 2006 |
Ojesina AI, Sankalé JL, Odaibo G, Langevin S, Meloni ST, Sarr AD, Olaleye D, Kanki PJ. Subtype-specific patterns in HIV Type 1 reverse transcriptase and protease in Oyo State, Nigeria: implications for drug resistance and host response. Aids Research and Human Retroviruses. 22: 770-9. PMID 16910833 DOI: 10.1089/Aid.2006.22.770 |
0.837 |
|
| 2006 |
MacNeil A, Sankalé JL, Meloni ST, Sarr AD, Mboup S, Kanki P. Genomic sites of human immunodeficiency virus type 2 (HIV-2) integration: similarities to HIV-1 in vitro and possible differences in vivo. Journal of Virology. 80: 7316-21. PMID 16840312 DOI: 10.1128/Jvi.00604-06 |
0.806 |
|
| 2006 |
Sankalé JL, Tong Q, Hadigan CM, Tan G, Grinspoon SK, Kanki PJ, Hotamisligil GS. Regulation of adiponectin in adipocytes upon exposure to HIV-1. Hiv Medicine. 7: 268-74. PMID 16630040 DOI: 10.1111/J.1468-1293.2006.00372.X |
0.527 |
|
| 2006 |
MacNeil A, Sankalé J, Meloni ST, Sarr AD, Mboup S, Kanki P. Long-term intrapatient evolution during HIV-2 infection Retrovirology. 3. DOI: 10.1186/1742-4690-3-S1-P38 |
0.802 |
|
| 2005 |
Hanson A, Sarr AD, Shea A, Jones N, Mboup S, Kanki P, Cao H. Distinct profile of T cell activation in HIV type 2 compared to HIV type 1 infection: differential mechanism for immunoprotection. Aids Research and Human Retroviruses. 21: 791-8. PMID 16218803 DOI: 10.1089/Aid.2005.21.791 |
0.571 |
|
| 2005 |
Idigbe EO, Adewole TA, Eisen G, Kanki P, Odunukwe NN, Onwujekwe DI, Audu RA, Araoyinbo ID, Onyewuche JI, Salu OB, Adedoyin JA, Musa AZ. Management of HIV-1 infection with a combination of nevirapine, stavudine, and lamivudine: a preliminary report on the Nigerian antiretroviral program. Journal of Acquired Immune Deficiency Syndromes (1999). 40: 65-9. PMID 16123684 DOI: 10.1097/01.Qai.0000159516.39982.1B |
0.566 |
|
| 2005 |
Sagay AS, Kapiga SH, Imade GE, Sankale JL, Idoko J, Kanki P. HIV infection among pregnant women in Nigeria International Journal of Gynecology and Obstetrics. 90: 61-67. PMID 15907849 DOI: 10.1016/J.Ijgo.2005.03.030 |
0.564 |
|
| 2005 |
Sarr AD, Eisen G, Guèye-Ndiaye A, Mullins C, Traoré I, Dia MC, Sankalé JL, Faye D, Mboup S, Kanki P. Viral dynamics of primary HIV-1 infection in Senegal, West Africa. The Journal of Infectious Diseases. 191: 1460-7. PMID 15809904 DOI: 10.1086/429409 |
0.586 |
|
| 2005 |
Adeokun LA, Ladipo OA, Odutolu O, Okonkwo P, Kanki P, Olaleye D, Delano G. Bridging the knowledge-behaviour gap through HIV/AIDS surveillance in four markets in Ogbomoso and Ibadan, Nigeria Archives of Ibadan Medicine. 5. DOI: 10.4314/Aim.V5I1.34610 |
0.5 |
|
| 2005 |
Kanki PJ, Essex ME. Virology The Aids Pandemic. 13-35. DOI: 10.1016/B978-012465271-2/50004-2 |
0.5 |
|
| 2005 |
Adeokun LA, Ladipo OA, Kanki P, Delano GE, Carrington A, Odimegwu CO. The role of HIV/AIDS prevention campaigns on HIV-related behavioural changes in Ibadan, Nigeria Etude De La Population Africaine. 20: 42-63. |
0.502 |
|
| 2004 |
Valadas E, Antunes F, Kanki P, Mullins C. HIV-2: The Portuguese connection [7] (multiple letters) Clinical Infectious Diseases. 39: 1553-1554. PMID 15546104 DOI: 10.1086/425506 |
0.502 |
|
| 2004 |
Meloni ST, Sankalé JL, Hamel DJ, Eisen G, Guéye-Ndiaye A, Mboup S, Kanki PJ. Molecular epidemiology of human immunodeficiency virus type 1 sub-subtype A3 in Senegal from 1988 to 2001. Journal of Virology. 78: 12455-61. PMID 15507632 DOI: 10.1128/Jvi.78.22.12455-12461.2004 |
0.766 |
|
| 2004 |
Meloni ST, Kim B, Sankalé JL, Hamel DJ, Tovanabutra S, Mboup S, McCutchan FE, Kanki PJ. Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3. Journal of Virology. 78: 12438-45. PMID 15507630 DOI: 10.1128/Jvi.78.22.12438-12445.2004 |
0.729 |
|
| 2004 |
McCutchan FE, Sankale JL, M'Boup S, Kim B, Tovanabutra S, Hamel DJ, Brodine SK, Kanki PJ, Birx DL. HIV type 1 circulating recombinant form CRF09_cpx from west Africa combines subtypes A, F, G, and may share ancestors with CRF02_AG and Z321. Aids Research and Human Retroviruses. 20: 819-26. PMID 15320986 DOI: 10.1089/0889222041725163 |
0.385 |
|
| 2004 |
Shea A, Dieng Sarr A, Jones N, Penning L, Eisen G, Gueye-Ndiaye A, Mboup S, Kanki P, Cao H. CCR5 receptor expression is down-regulated in HIV type 2 infection: Implication for viral control and protection Aids Research and Human Retroviruses. 20: 630-635. PMID 15242539 DOI: 10.1089/0889222041217383 |
0.586 |
|
| 2004 |
Mullins C, Eisen G, Popper S, Dieng Sarr A, Sankale JL, Berger JJ, Wright SB, Chang HR, Coste G, Cooley TP, Rice P, Skolnik PR, Sullivan M, Kanki PJ. Highly active antiretroviral therapy and viral response in HIV type 2 infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 38: 1771-9. PMID 15227626 DOI: 10.1086/421390 |
0.564 |
|
| 2004 |
Sankalé JL, Kanki PJ. Virologic and Biologic Features of Human Immunodeficiency Virus Type 2 (HIV-2) Aids and Other Manifestations of Hiv Infection. 131-145. DOI: 10.1016/B978-012764051-8/50009-3 |
0.538 |
|
| 2003 |
Tong Q, Sankalé JL, Hadigan CM, Tan G, Rosenberg ES, Kanki PJ, Grinspoon SK, Hotamisligil GS. Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices. The Journal of Clinical Endocrinology and Metabolism. 88: 1559-64. PMID 12679439 DOI: 10.1210/Jc.2002-021600 |
0.447 |
|
| 2003 |
Gilbert PB, McKeague IW, Eisen G, Mullins C, Guéye-NDiaye A, Mboup S, Kanki PJ. Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal. Statistics in Medicine. 22: 573-93. PMID 12590415 DOI: 10.1002/sim.1342 |
0.546 |
|
| 2002 |
Mani I, Gilbert P, Sankalé JL, Eisen G, Mboup S, Kanki PJ. Intrapatient diversity and its correlation with viral setpoint in human immunodeficiency virus type 1 CRF02_A/G-IbNG infection. Journal of Virology. 76: 10745-55. PMID 12368317 DOI: 10.1128/JVI.76.21.10745-10755.2002 |
0.353 |
|
| 2002 |
Diouf K, Sarr AD, Eisen G, Popper S, Mboup S, Kanki P. Associations between MHC class I and susceptibility to HIV-2 disease progression. Journal of Human Virology. 5: 1-7. PMID 12352262 |
0.444 |
|
| 2001 |
Dieye TN, Sow PS, Simonart T, Guèye-Ndiaye A, Popper SJ, Delforge ML, Dieye A, Sarr AD, Crusiaux A, Vooren JPV, Devleeschouwer M, Kanki P, Mboup S, Diakhate L, Farber CM. Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals Vaccine. 20: 905-913. PMID 11738756 DOI: 10.1016/S0264-410X(01)00383-8 |
0.608 |
|
| 2001 |
Sarr AD, Lu Y, Sankalé JL, Eisen G, Popper S, Mboup S, Kanki PJ, Cao H. Robust HIV Type 2 cellular immune response measured by a modified anthrax toxin-based enzyme-linked immunospot assay Aids Research and Human Retroviruses. 17: 1257-1264. PMID 11559425 DOI: 10.1089/088922201750461311 |
0.409 |
|
| 2000 |
Cao H, Mani I, Vincent R, Mugerwa R, Mugyenyi P, Kanki P, Ellner J, Walker BD. Cellular immunity to Human Immunodeficiency Virus type 1 (HIV-1) clades: Relevance to HIV-1 vaccine trials in Uganda Journal of Infectious Diseases. 182: 1350-1356. PMID 11023458 DOI: 10.1086/315868 |
0.516 |
|
| 2000 |
Sturm-Ramirez K, Gaye-Diallo A, Eisen G, Mboup S, Kanki PJ. High levels of tumor necrosis factor-α and interleukin-1β in bacterial vaginosis may increase susceptibility to human immunodeficiency virus Journal of Infectious Diseases. 182: 467-473. PMID 10915077 DOI: 10.1086/315713 |
0.704 |
|
| 2000 |
Sankalé JL, Hamel D, Woolsey A, Traoré I, Dia MC, Guèye-Ndiaye A, Essex M, Mboup S, Kanki P. Molecular evolution of human immunodeficiency virus type 1 subtype A in Senegal: 1988-1997 Journal of Human Virology. 3: 157-164. PMID 10881996 |
0.467 |
|
| 2000 |
Kokkotou EG, Sankalé JL, Mani I, Guèye-Ndiaye A, Schwartz D, Essex ME, Mboup S, Kanki PJ. In vitro correlates of HIV-2-mediated HIV-1 protection Proceedings of the National Academy of Sciences of the United States of America. 97: 6797-6802. PMID 10841574 DOI: 10.1073/pnas.97.12.6797 |
0.536 |
|
| 2000 |
Malone JD, Sheffield J, Tribble D, Lowe-Bey F, Cannon M, Slaughter-Allen M, Brown AE, Kanki PJ. Evaluation of three rapid/simple tests for detection of HIV-2 antibodies. Journal of Acquired Immune Deficiency Syndromes (1999). 23: 281-3. PMID 10839666 |
0.402 |
|
| 2000 |
Castillo RC, Arango-Jaramillo S, John R, Weinhold K, Kanki P, Carruth L, Schwartz DH. Resistance to human immunodeficiency virus type 1 in vitro as a surrogate of vaccine-induced protective immunity. The Journal of Infectious Diseases. 181: 897-903. PMID 10720510 DOI: 10.1086/315300 |
0.573 |
|
| 2000 |
Dieng Sarr A, Sankalé JL, Guèye-Ndiaye A, Essex M, Mboup S, Kanki PJ. Genetic analysis of HIV type 2 in monotypic and dual HIV infections Aids Research and Human Retroviruses. 16: 295-298. PMID 10710218 DOI: 10.1089/088922200309395 |
0.535 |
|
| 2000 |
Sarr AD, Sankalé JL, Hamel DJ, Travers KU, Guèye-Ndiaye A, Essex M, Mboup S, Kanki PJ. Interaction with human immunodeficiency virus (HIV) type 2 predicts HIV type 1 genotype. Virology. 268: 402-10. PMID 10704348 DOI: 10.1006/Viro.2000.0192 |
0.544 |
|
| 2000 |
Popper SJ, Dieng Sarr A, Guèye-Ndiaye A, Mboup S, Essex ME, Kanki PJ. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: Low virus production in vivo Journal of Virology. 74: 1554-1557. PMID 10627569 DOI: 10.1128/JVI.74.3.1554-1557.2000 |
0.461 |
|
| 1999 |
Popper SJ, Sarr AD, Travers KU, Guèye-Ndiaye A, Mboup S, Essex ME, Kanki PJ. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2 Journal of Infectious Diseases. 180: 1116-1121. PMID 10479138 DOI: 10.1086/315010 |
0.521 |
|
| 1999 |
Plantier JC, Damond F, Lasky M, Sankalé JL, Apetrei C, Peeters M, Buzelay L, M'Boup S, Kanki P, Delaporte E, Simon F, Barin F. V3 serotyping of HIV-1 infection: Correlation with genotyping and limitations Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 20: 432-441. PMID 10225224 DOI: 10.1097/00042560-199904150-00004 |
0.392 |
|
| 1999 |
Sarr AD, Popper S, Thior I, Hamel DJ, Sankalé JL, Siby T, Marlink R, Essex M, Mboup S, Kanki P. Relation between HIV-2 proviral load and CD4+ lymphocyte count differs in monotypic and dual HIV infections. Journal of Human Virology. 2: 45-51. PMID 10200599 |
0.495 |
|
| 1999 |
Kanki PJ, Hamel DJ, Sankalé JL, Hsieh Cc, Thior I, Barin F, Woodcock SA, Guèye-Ndiaye A, Zhang E, Montano M, Siby T, Marlink R, NDoye I, Essex ME, MBoup S. Human immunodeficiency virus type 1 subtypes differ in disease progression. The Journal of Infectious Diseases. 179: 68-73. PMID 9841824 DOI: 10.1086/314557 |
0.535 |
|
| 1998 |
Kokkotou E, Philippon V, Guèye-Ndiaye A, Mboup S, Wang WK, Essex M, Kanki P. Role of the CCR5Δ32 allele in resistance to HIV-1 infection in West Africa Journal of Human Virology. 1: 469-474. PMID 10195268 |
0.534 |
|
| 1998 |
Clark NM, Dieng Sarr A, Sankale JL, Kanki PJ, Kazanjian P, Winfield R, Markovitz DM. Immunologic and virologic response of HIV-2 infection to antiretroviral therapy [5] Aids. 12: 2506-2507. PMID 9875594 |
0.498 |
|
| 1998 |
Sankale JL, Mboup S, Essex ME, Kanki PJ. Genetic characterization of viral quasispecies in blood and cervical secretions of HIV-1- and HIV-2-infected women Aids Research and Human Retroviruses. 14: 1473-1481. PMID 9824325 |
0.528 |
|
| 1998 |
Popper SJ, Sankalé JL, Thior I, Siby T, Marlink RG, Mboup S, Essex M, Kanki PJ. Antibodies to the HIV type 2 core protein p26 and Vpx: Association with disease progression Aids Research and Human Retroviruses. 14: 1157-1162. PMID 9737587 DOI: 10.1089/Aid.1998.14.1157 |
0.385 |
|
| 1998 |
Travers KU, Eisen GE, Marlink RG, Essex ME, Hsieh CC, Mboup S, Kanki PJ. Protection from HIV-1 infection by HIV-2 [6] Aids. 12: 224-225. PMID 9468377 |
0.538 |
|
| 1998 |
Sarr AD, Hamel DJ, Thior I, Kokkotou E, Sankalé JL, Marlink RG, Coll-Seck EM, Essex ME, Siby T, NDoye I, Mboup S, Kanki PJ. HIV-1 and HIV-2 dual infection: lack of HIV-2 provirus correlates with low CD4+ lymphocyte counts. Aids (London, England). 12: 131-7. PMID 9468361 DOI: 10.1097/00002030-199802000-00002 |
0.521 |
|
| 1997 |
Thior I, Diouf G, Diaw IK, Sarr AD, Hsieh CC, Ndoye I, Mboup S, Chen L, Essex M, Marlink R, Kanki P. Sexually transmitted diseases and risk of HIV infection in men attending a sexually transmitted diseases clinic in Dakar, Senegal African Journal of Reproductive Health. 1: 26-35. PMID 10214412 DOI: 10.2307/3583374 |
0.534 |
|
| 1997 |
Kanki PJ, Peeters M, Guéye-Ndiaye A. Virology of HIV-1 and HIV-2: implications for Africa Aids (London, England). 11. PMID 9416365 |
0.535 |
|
| 1997 |
Cao H, Kanki P, Sankalé JL, Dieng-Sarr A, Mazzara GP, Kalams SA, Korber B, Mboup S, Walker BD. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: Implications for vaccine development Journal of Virology. 71: 8615-8623. PMID 9343219 DOI: 10.1128/Jvi.71.11.8615-8623.1997 |
0.528 |
|
| 1996 |
Kanki PJ, Eisen G, Travers KU, Marlink RG, Essex ME, Hsieh CC, Mboup S. Response: HIV-2 and Natural Protection Against HIV-1 Infection. Science (New York, N.Y.). 272: 1959b-60b. PMID 17774134 DOI: 10.1126/science.272.5270.1959b |
0.532 |
|
| 1996 |
Sankalé JL, De La Tour RS, Marlink RG, Scheib R, Mboup S, Essex ME, Kanki PJ. Distinct quasi-species in the blood and the brain of an HIV-2-infected individual Virology. 226: 418-423. PMID 8955063 DOI: 10.1006/viro.1996.0671 |
0.446 |
|
| 1995 |
Sankale JL, De la Tour RS, Renjifo B, Siby T, Mboup S, Marlink RG, Essex ME, Kanki PJ. Intrapatient variability of the human immunodeficiency virus type 2 envelope V3 loop Aids Research and Human Retroviruses. 11: 617-623. PMID 7576918 |
0.524 |
|
| 1995 |
Travers K, Mboup S, Marlink R, Gueye-Ndiaye A, Siby T, Thior I, Traore I, Dieng-Sarr A, Sankale JL, Mullins C, Ndoye I, Hsieh CC, Essex M, Kanki P. Natural protection against HIV-1 infection provided by HIV-2 Science. 268: 1612-1615. PMID 7539936 |
0.544 |
|
| 1994 |
Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, Traore I, Hsieh CC, Dia MC, Gueye EH, Hellinger J, Guèye-Ndiaye A, Sankalé JL, Ndoye I, Mboup S, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1 Science. 265: 1587-1590. PMID 7915856 DOI: 10.1126/Science.7915856 |
0.625 |
|
| 1994 |
Kanki PJ, Travers KU, Marlink RG, Essex ME, MBoup S, Gueye-NDiaye A, Siby T, Thior I, Sankalé JL, Hsieh CC, Hernandez-Avila M, NDoye I. Slower heterosexual spread of HIV-2 than HIV-1 The Lancet. 343: 943-946. PMID 7909009 DOI: 10.1016/S0140-6736(94)90065-5 |
0.542 |
|
| 1994 |
Kanki PJ, De Cock KM. Epidemiology and natural history of HIV-2 Aids. 8. |
0.51 |
|
| 1993 |
Kashala O, Kayembe K, Kanki P, Mukeba P, Diese M, Kalengayi M, Izzia KW, Essex M. Humoral aspects of anti-HIV immune responses in Zairians with AIDS: Lower antigenemia does not correlate with immune complex levels Aids Research and Human Retroviruses. 9: 251-258. PMID 8471316 DOI: 10.1089/Aid.1993.9.251 |
0.531 |
|
| 1993 |
Donnelly C, Leisenring W, Kanki P, Awerbuch T, Sandberg S. Comparison of transmission rates of HIV-1 and HIV-2 in a cohort of prostitutes in Senegal Bulletin of Mathematical Biology. 55: 731-743. PMID 8318928 DOI: 10.1016/S0092-8240(05)80187-9 |
0.605 |
|
| 1993 |
Kane F, Alary M, Ndoye I, Coll AM, M'boup S, Guèye A, Kanki PJ, Joly JR. Temporary expatriation is related to HIV-1 infection in rural Senegal Aids. 7: 1261-1265. PMID 8216985 DOI: 10.1097/00002030-199309000-00017 |
0.61 |
|
| 1992 |
Kanki PJ, M'Boup S, Marlink R, Travers K, Hsieh CC, Gueye A, Boye C, Sankale JL, Donnelly C, Leisenring W, Siby T, Thior I, Dia M, Gueye - EH, N'Doye I, et al. Prevalence and risk determinants of human immunodeficiency virus type 2 (HIV-2) and human immunodeficiency virus type 1 (HIV-1) in West African female prostitutes American Journal of Epidemiology. 136: 895-907. PMID 1442755 DOI: 10.1093/Aje/136.7.895 |
0.599 |
|
| 1991 |
Kanki PJ. Biologic features of HIV-2. An update Aids Clinical Review. 17-38. PMID 1868007 |
0.476 |
|
| 1991 |
Baillou A, Janvier B, Mayer R, Kanki P, M'Boup S, Denis F, Goudeau A, Essex M, Barin F. Site-directed serology using synthetic oligopeptides representing the C-terminus of the external glycoproteins of HIV-1, HIV-2, or SIV(mac) may distinguish subtypes among primate lentiviruses Aids Research and Human Retroviruses. 7: 767-771. PMID 1720632 DOI: 10.1089/Aid.1991.7.767 |
0.566 |
|
| 1991 |
M'Boup S, Kanki PJ, Mhalu FS. Laboratory diagnosis of HIV-1 and HIV-2 in Africa Aids. 5. PMID 1669930 |
0.499 |
|
| 1990 |
Romieu I, Marlink R, Kanki P, M'Boup S, Essex M. HIV-2 link to AIDS in west africa Journal of Acquired Immune Deficiency Syndromes. 3: 220-230. PMID 2406413 |
0.548 |
|
| 1990 |
Essex M, Kanki PJ, Marlink R, Chou MJ, Lee TH. Antigenic characterization of the human immunodeficiency viruses Journal of the American Academy of Dermatology. 22: 1206-1210. PMID 2193947 DOI: 10.1016/0190-9622(90)70164-D |
0.484 |
|
| 1990 |
Zuber M, Samuel KP, Lautenberger JA, Kanki PJ, Papas TS. Bacterially produced HIV-2 env polypeptides specific for distinguishing HIV-2 from HIV-1 infections Aids Research and Human Retroviruses. 6: 525-532. PMID 2187502 |
0.519 |
|
| 1989 |
Ayanian JZ, Maguire JH, Marlink RG, Essex M, Kanki PJ. HIV-2 infection in the United States New England Journal of Medicine. 320: 1422-1423. PMID 2716792 DOI: 10.1056/Nejm198905253202119 |
0.462 |
|
| 1989 |
Kanki PJ. Clinical significance of HIV-2 infection in West Africa Aids Clinical Review. 95-108. PMID 2577365 |
0.503 |
|
| 1989 |
Fincham JE, Van der Riet F, Steytler JG, Tung MT, Cooper R, Seier JV, Madden DL, Kanki P, Campbell JA, Taljaard JJ. Increased peripheral lymphocytes, lymphoid hepatitis and anaemia in African vervet monkeys seropositive to retroviruses. Journal of Comparative Pathology. 101: 53-68. PMID 2551937 DOI: 10.1016/0021-9975(89)90076-5 |
0.332 |
|
| 1989 |
Essex M, Matsuda Z, Yu X, Kanki P, Lee T. Immunology of HIV Vaccine. 7: 188. DOI: 10.1016/0264-410X(89)90133-3 |
0.598 |
|
| 1988 |
Marlink RG, Ricard D, M'Boup S, Kanki PJ, Romet-Lemonne JL, N'Doye I, Diop K, Simpson MA, Greco F, Chou MJ. Clinical, hematologic, and immunologic cross-sectional evaluation of individuals exposed to human immunodeficiency virus type-2 (HIV-2). Aids Research and Human Retroviruses. 4: 137-48. PMID 3259142 DOI: 10.1089/Aid.1988.4.137 |
0.52 |
|
| 1988 |
Varnier OE, Lillo FB, Schito GC, Lazzarin A, Kanki PJ. Parallel Western blot analysis for HIV-1 and HIV-2 antibodies: Absence of HIV-2 infection in Italian subjects at risk for AIDS Aids. 2: 215-217. PMID 3134917 |
0.548 |
|
| 1988 |
Essex M, Kanki PJ. The origins of the AIDS virus Scientific American. 259: 64-71. PMID 2907683 DOI: 10.1038/Scientificamerican1088-64 |
0.467 |
|
| 1988 |
Hoxie JA, Haggarty BS, Bonser SE, Rackowski JL, Shan H, Kanki PJ. Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): Evidence for CD4-associated molecules required for infection Journal of Virology. 62: 2557-2568. PMID 2839686 DOI: 10.1128/Jvi.62.8.2557-2568.1988 |
0.348 |
|
| 1988 |
ESSEX M, KANKI P. Comparison of simian immunodeficiency virus isolates Nature. 331: 621-622. DOI: 10.1038/331621A0 |
0.303 |
|
| 1987 |
Kanki PJ. West African human retroviruses related to STLV-III Aids. 1: 141-145. PMID 3126753 |
0.483 |
|
| 1987 |
Franchini G, Collalti E, Arya SK, Fenyo EM, Biberfeld G, Zagury JF, Kanki PJ, Wong-Staal F, Gallo RC. Genetic analysis of a new subgroup of human and simian T-lymphotropic retroviruses: HTLV-IV, LAV-2, SBL-6669, and STLV-III(AGM) Aids Research and Human Retroviruses. 3: 11-17. PMID 3040052 DOI: 10.1089/Aid.1987.3.11 |
0.36 |
|
| 1987 |
Arya SK, Beaver B, Jagodzinski L, Ensoli B, Kanki PJ, Albert J, Fenyo EM, Biberfeld G, Zagury JF, Laure F. New human and simian HIV-related retroviruses possess functional transactivator (tat) gene Nature. 328: 548-550. PMID 3039372 DOI: 10.1038/328548A0 |
0.444 |
|
| 1987 |
Kanki PJ, M'Boup S, Ricard D, Barin F, Denis F, Boye C, Sangare L, Travers K, Albaum M, Marlink R. Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa Science. 236: 827-831. PMID 3033826 DOI: 10.1126/science.3033826 |
0.426 |
|
| 1987 |
Kanki PJ, Hopper JR, Essex M. The origins of HIV-1 and HTLV-4/HIV-2 Annals of the New York Academy of Sciences. 511: 370-375. PMID 2894192 DOI: 10.1111/j.1749-6632.1987.tb36265.x |
0.486 |
|
| 1987 |
Kanki PJ, Allan J, Barin F, Redfield R, Clumeck N, Quinn T, Mowovondi F, Thiry L, Burny A, Zagury D. Absence of antibodies to HIV-2/HTLV-4 in six central African nations. Aids Research and Human Retroviruses. 3: 317-22. PMID 2893632 DOI: 10.1089/Aid.1987.3.317 |
0.545 |
|
| 1987 |
Barin F, Denis F, Baillou A, Leonard G, Mounier M, M'Boup S, Gershy-Damet G, Sangare A, Kanki P, Essex M. A STLV-III related human retrovirus, HTLV-IV: analysis of cross-reactivity with the human immunodeficiency virus (HIV). Journal of Virological Methods. 17: 55-61. PMID 2444614 DOI: 10.1016/0166-0934(87)90068-1 |
0.55 |
|
| 1986 |
Nahmias AJ, Weiss J, Yao X, Lee F, Kodsi R, Schanfield M, Matthews T, Bolognesi D, Durack D, Motulsky A, Kanki P, Essex M. EVIDENCE FOR HUMAN INFECTION WITH AN HTLV III/LAV-LIKE VIRUS IN CENTRAL AFRICA, 1959 The Lancet. 327: 1279-1280. PMID 2872424 DOI: 10.1016/S0140-6736(86)91422-4 |
0.305 |
|
| 1985 |
Kanki PJ, McLane MF, King NW, Letvin NL, Hunt RD, Sehgal P, Daniel MD, Desrosiers RC, Essex M. Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III. Science (New York, N.Y.). 228: 1199-201. PMID 3873705 DOI: 10.1126/Science.3873705 |
0.306 |
|
| 1985 |
Kanki PJ, Alroy J, Essex M. Isolation of T-lymphotropic retrovirus relatedto HTLV-III/LAV from wild-caught African green monkeys Science. 230: 951-954. PMID 2997923 DOI: 10.1126/Science.2997923 |
0.324 |
|
| Show low-probability matches. |